Minigene Assay as an Effective Molecular Diagnostic Strategy in Determining the Pathogenicity of Noncanonical Splice-Site Variants in FLCN
Xinxin Zhang(Ruijin Hospital), Long Yi(Nanjing University), Xiaowen Hu(Lanzhou University), Shaoping Huang(Southeast University), Minghui Cai(Wenzhou Medical University), Jie Chen(Nanjing University), Qian Gao(Yale University), Yibing Ding(China Pharmaceutical University), Dehua Ma(Wenzhou Medical University), Yuanchun Ma(Nanjing University), Chengchu Zhu(Bristol-Myers Squibb (Germany)), Mengru Cai(Nanjing University)
Cited by 8
Related Papers
Neoadjuvant Chemoradiotherapy Followed by Surgery Versus Surgery Alone for Locally Advanced Squamous Cell Carcinoma of the Esophagus (NEOCRTEC5010): A Phase III Multicenter, Randomized, Open-Label Clinical Trial
|Journal of Clinical Oncology|2018|976
BRAF V600E Expression in Langerhans Cell Histiocytosis
|The American Journal of Surgical Pathology|2014|162
Factors associated with negative conversion of viral RNA in patients hospitalized with COVID-19
|The Science of The Total Environment|2020|158
Aspiration-Related Pulmonary Syndromes
|CHEST Journal|2015|155